Nanumi Han, Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Takuto Kobayashi, Haruka Wada, . . . Ken-ichiro Seino. (2018). Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma. BMC.
Chicago Style (17th ed.) CitationNanumi Han, Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Takuto Kobayashi, Haruka Wada, Keisuke Imafuku, Hiroo Hata, and Ken-ichiro Seino. Enhanced IL-34 Expression in Nivolumab-resistant Metastatic Melanoma. BMC, 2018.
MLA (9th ed.) CitationNanumi Han, et al. Enhanced IL-34 Expression in Nivolumab-resistant Metastatic Melanoma. BMC, 2018.
Warning: These citations may not always be 100% accurate.